-
FRONT PEDIATR 2024 10.3389/fped.2024.1479619
Risk factors affecting relapse after discontinuation of biologics in children with Crohn's disease who maintained deep remission
Kim, H; Kim, YZ; Kim, SY; Choe, YH; Kim, MJ
View PubMed
-
THER DRUG MONIT 2024 10.1097/FTD.0000000000001176
Fluorescence-Based Lateral Flow Immunoassay for Quantification of Infliximab: Analytical and Clinical Performance Evaluation
Kim, ES; Chon, H; Kwon, Y; Lee, M; Kim, MJ; Choe, YH
View PubMed
-
FRONT PEDIATR 2024 10.3389/fped.2023.1242009
Long-term outcomes of liver transplantation for biliary atresia and results of policy changes: over 20 years of follow-up experience
Kwon, Y; Ahn, YJ; Yang, JH; Kim, ES; Choe, YH; Lee, SH; Kim, MJ
View PubMed
-
J KOREAN MED SCI 2023 10.3346/jkms.2023.38.e401
A Report on a Nationwide Surveillance System for Pediatric Acute Hepatitis of Unknown Etiology in Korea
Lee, KJ; Ko, JS; Park, KY; Kang, KS; Lee, KS; Hong, JA; Kim, SC; Lee, Y; Kang, B; Kim, YB; Kim, HJ; Eun, BW; Cho, HK; Kim, YJ; Kim, MJ; Lee, J; Lee, TJ; Oh, SH; Park, S; Ha Hwang, E; Sohn, S; Lim, JG; Kim, Y; Lee, YJ
View PubMed
-
BIOMEDICINES 2023 10.3390/biomedicines11092575
Efficacy of Combined Initial Treatment of Methotrexate with Infliximab in Pediatric Crohn's Disease: A Pilot Study
Kim, YZ; Kang, B; Kim, ES; Kwon, Y; Choe, YH; Kim, MJ
View PubMed
-
FRONT MED-LAUSANNE 2023 10.3389/fmed.2023.1231066
Impact of the histologic grade of acute gastrointestinal graft-versus-host disease on outcomes in pediatric patients treated with allogeneic hematopoietic stem cell transplantation
Kim, ES; Kwon, Y; Choe, YH; Kim, MJ; Yoo, KH
View PubMed
-
THER ADV GASTROENTER 2023 10.1177/17562848231170948
Free antibodies-to-infliximab are biomarker for predicting the effect of dose intensification in pediatric Crohn's disease patients with secondary loss of response
Kim, ES; Kwon, Y; Choe, YH; Kim, MJ
View PubMed
-
ANN DERMATOL 2023 10.5021/ad.21.060
Dual Biological Therapy for Ulcerative Colitis with Intractable Pyoderma Gangrenosum
Lee, HC; Kwon, Y; Kim, ES; Ahn, S; Choe, YH; Kim, MJ
View PubMed
-
J KOREAN MED SCI 2023 10.3346/jkms.2023.38.e71
The Changes in Respiratory and Enteric Adenovirus Epidemiology in Korea From 2017 to June 2022
Kim, KR; Won, J; Kim, H; Kim, BI; Kim, MJ; Kim, JY; Gwack, J; Kim, YJ
View PubMed
-
FRONT IMMUNOL 2022 10.3389/fimmu.2022.996875
Increased monocyte abundance as a marker for relapse after discontinuation of biologics in inflammatory bowel disease with deep remission
Kwon, Y; Kim, YZ; Choe, YH; Kim, MJ
View PubMed
-
BIOMEDICINES 2022 10.3390/biomedicines10102372
Cytokine Profile at Diagnosis Affecting Trough Concentration of Infliximab in Pediatric Crohn's Disease
Kwon, Y; Kim, ES; Kim, YZ; Choe, YH; Kim, MJ
View PubMed
-
J KOREAN MED SCI 2022 10.3346/jkms.2022.37.e282
Vedolizumab Is Safe and Efficacious for the Treatment of Pediatric-Onset Inflammatory Bowel Disease Patients Who Fail a Primary Biologic Agent
Choi, S; Kim, ES; Kwon, Y; Kim, MJ; Choe, YH; Choe, BH; Kang, B
View PubMed
-
GUT LIVER 2022 10.5009/gnl210488
Comparison between Pediatric Crohn's Disease and Ulcerative Colitis at Diagnosis in Korea: Results from a Multicenter, Registry-Based, Inception Cohort Study
Park, S; Kang, B; Kim, S; Choi, S; Suh, HR; Kim, ES; Park, JH; Kim, MJ; Choe, YH; Lee, YJ; Park, JH; Ryoo, E; Koh, H; Choe, BH
View PubMed
-
THER DRUG MONIT 2022 10.1097/FTD.0000000000000976
Comparison of Ustekinumab Trough Concentrations Measured by 2 ELISA Kits and Evaluation of Clinical Response in Crohn's Disease
Kwon, Y; Kang, B; Kim, ES; Choe, YH; Kim, MJ
View PubMed
-
WORLD J GASTROENTERO 2022 10.3748/wjg.v28.i28.3666
How has the disease course of pediatric ulcerative colitis changed throughout the biologics era? A comparison with the IBSEN study
Kwon, Y; Kim, ES; Choe, YH; Kim, MJ
View PubMed
-
FRONT PEDIATR 2022 10.3389/fped.2022.853019
Increased Demand for Therapeutic Drugs in Pediatric Ulcerative Colitis Patients With Extraintestinal Manifestations
Kwon, Y; Kim, ES; Choe, YH; Kim, MJ
View PubMed
-
FRONT PEDIATR 2022 10.3389/fped.2022.846273
Stratification by Non-invasive Biomarkers of Non-alcoholic Fatty Liver Disease in Children
Kwon, Y; Kim, ES; Choe, YH; Kim, MJ
View PubMed
-
SCI REP-UK 2022 10.1038/s41598-021-04304-6
Discontinuation of Azathioprine could be considered in pediatric patients with Crohn's disease who have sustained clinical and deep remission
Jeong, TJ; Kim, ES; Kwon, Y; Kim, S; Seo, SW; Choe, YH; Kim, MJ
View PubMed
-
ALIMENT PHARM THER 2022 10.1111/apt.16769
NUDT15 intermediate metabolisers are associated with lower loss of response in paediatric Crohn's disease patients treated by combination treatment with infliximab and azathioprine
Kim, ES; Choi, S; Choi, SY; Park, JH; Choe, BH; Lee, SY; Kim, MJ; Choe, YH; Kang, B
View PubMed
-
J PEDIATR GASTR NUTR 2021 10.1097/MPG.0000000000003070 2021
Therapeutic Drug Monitoring of Adalimumab During Long-term Follow-up in Paediatric Patients With Crohn Disease
Kim1, MJ; Kim, E; Kang, B; Choe, YH
View PubMed
-
YONSEI MED J 2021 10.3349/ymj.2021.62.5.470 2021
Therapeutic Lymphatic Embolization in Pediatric Primary Intestinal Lymphangiectasia
Kwon1, Y; Kim, ES; Choe, YH; Hyun, D; Kim, MJ
View PubMed
-
SCI REP-UK 2021 10.1038/s41598-021-84766-w 2021
COVID-19-related school closing aggravate obesity and glucose intolerance in pediatric patients with obesity
Kim1, ES; Kwon, Y; Choe, YH; Kim, MJ
View PubMed
-
BMC PEDIATR 2021 10.1186/s12887-020-02447-5 2021
Individual approach for treatment of primary intestinal lymphangiectasia in children: single-center experience and review of the literature
Kwon1, Y; Kim, ES; Choe, YH; Kim, MJ
View PubMed
-
GUT LIVER 2021 10.5009/gnl20212
Anti-Saccharomyces cerevisiae Antibody in Pediatric Crohn's Disease Patients without Mucosal Healing Is a Useful Marker of Mucosal Damage
Kim, MJ; Kim, E; Kang, B; Lee, Y; Kang, ES; Choe, YH
View PubMed
-
FRONT IMMUNOL 2021 10.3389/fimmu.2021.698721
Needs for Increased Awareness of Gastrointestinal Manifestations in Patients With Human Inborn Errors of Immunity
Kim, ES; Kim, D; Yoon, Y; Kwon, Y; Park, S; Kim, J; Ahn, KM; Ahn, S; Choe, YH; Kim, YJ; Kim, MJ
View PubMed
-
YONSEI MED J 2021 10.3349/ymj.2021.62.7.608
Infliximab Therapy for Children with Moderate to Severe Ulcerative Colitis: A Step-Up versus a Top-Down Strategy
Kim, MJ; Kim, E; Kang, B; Choe, YH
View PubMed
-
PHARMACOGEN PERS MED 2020 10.2147/PGPM.S279446 2020
The Identification of a Novel Thiopurine S-Methyltransferase Allele, TPMT*45, in Korean Patient with Crohn's Disease
Ha1, C; Kim, ES; Kwon, Y; Choe, YH; Kim, MJ; Lee, SY
View PubMed
-
SCI REP-UK 2020 10.1038/s41598-020-75938-1 2020
Upper gastrointestinal tract involvement is more prevalent in Korean patients with pediatric Crohn's disease than in European patients
Kim1, ES; Kwon, Y; Choe, YH; Kim, MJ
View PubMed
-
FRONT MICROBIOL 2020 10.3389/fmicb.2020.02099 2020
Delayed Establishment of Gut Microbiota in Infants Delivered by Cesarean Section
Kim1, G; Bae, J; Kim, MJ; Kwon, H; Park, G; Kim, SJ; Choe, YH; Kim, J; Park, SH; Choe, BH; Shin, H; Kang, B
View PubMed
-
INDIAN PEDIATR 2019 10.1007/s13312-019-1649-5 2019
Correlation of Dickkopf-1 with Inflammation in Crohn Disease
Kim1, MJ; Choe, YH
View PubMed
